FDA Inspection
Lane, Danielle E MDLane, Danielle E MD – FDA Inspection, Jan 31, 2014
Record Details
This FDA Inspection record concerns Lane, Danielle E MD, with an inspection on January 31, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Lane, Danielle E MD
- Inspection Date
- January 31, 2014
- Product Type
- Biologics
View Company Profile
ID · c7f7a057-2773-47bf-92aa-f8a331117b4a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 863938
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.65(a)Improper release prevention--storage, I.D.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lane, Danielle E MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 6, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 2, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 27, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Lane, Danielle E MD
- FDA Inspection 1273928 - 2025-05-06
- FDA Inspection 1199415 - 2023-03-02
- FDA Inspection 1014197 - 2017-04-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.